Robertson Stephen P. — SEC Form 4 filings
SEC reporting owner CIK 1837798. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-22 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 5 filings — 232,782 shares, $2,017,443 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 64,872 shares @ $8.00 ($518,976) in Aurinia Pharmaceuticals Inc., filed 2025-03-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | Chief Legal Officer | 10 | — | 6 legs · 232,782 sh · $2,017,443 | 11 |
Form 4 filings — Robertson Stephen P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 11,939 @ $15.95 | EDGAR |
| 2026-08-25 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 20,975 @ $16.97 | EDGAR |
| 2026-05-20 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 115,541 @ $0 | EDGAR |
| 2026-03-03 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 59,090 @ $0 · Tax withholding (F): 36,525 @ $14.21 · Grant/award (A): 98,813 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax withholding (F): 34,638 @ $14.40 | EDGAR |
| 2026-01-05 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 48,558 @ $0 · Tax withholding (F): 40,385 @ $15.95 | EDGAR |
| 2025-03-04 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 84,106 @ $0 · Grant/award (A): 102,406 @ $0 · Sale (S): 64,872 @ $8 · Sale (S): 57,607 @ $7.92 · Grant/award (A): 128,438 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 57,745 @ $5.60 | EDGAR |
| 2024-02-22 | 4/A | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 19,644 @ $8.78 | EDGAR |
| 2024-02-22 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 194,230 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1837798 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →